Concepedia

Author

Maria Kuzikov

Fraunhofer Institute for Molecular Biology and Applied EcologyORCID

Also Known As

Bernhard Ellinger, Kuzikov, Maria, M. Kuzikov, Maria Kuzikov, Phil Gribbon

91

Publications

1.6K

Citations

19

H-Index

31

Concepts

All Affiliations

Fraunhofer Institute for Molecular Biology and Applied EcologyUniversity of Modena and Reggio EmiliaFraunhofer Institute for Translational Medicine and Pharmacologyi3S - Instituto de Investigação e Inovação em Saúde, Universidade do PortoBrazilian Biosciences National Laboratory
MK

About

Maria Kuzikov is an author at Fraunhofer Institute for Molecular Biology and Applied Ecology specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

237

2

Natural Sciences

7

7

195

3

Biochemistry

7

7

201

4

Chemical Biology

4

4

123

5

Biomolecular Engineering

2

2

27

Maria Kuzikov

×

31

Publications

1.1K

Citations

18

H-Index

YearCitations

Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen

Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen,

ACS Pharmacology & Translational Science

2021

154

Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain

Marco Sisignano, Carlo Angioni, Chul‐Kyu Park,

Proceedings of the National Academy of Sciences

2016

95

A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection

Bernhard Ellinger, Denisa Bojková, Andrea Zaliani,

Scientific Data

2021

86

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L

Elisa Costanzi, Maria Kuzikov, Francesca Esposito,

International Journal of Molecular Sciences

2021

84

Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection

Bernhard Ellinger, Denisa Bojková, Andrea Zaliani,

Research Square (Research Square)

2020

77

A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics

Simone Albani, Anton Hanke, Benjamin P. Joseph,

ACS Pharmacology & Translational Science

2021

65

Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity

F. Di Pisa, Giacomo Landi, Lucia Dello Iacono,

Molecules

2017

64

Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs

Chiara Borsari, Rosaria Luciani, Cecilia Pozzi,

Journal of Medicinal Chemistry

2016

55

Aryl thiosemicarbazones for the treatment of trypanosomatidic infections

Pasquale Linciano, Carolina Borsoi Moraes, Laura Maria Alcântara,

European Journal of Medicinal Chemistry

2018

40

Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort

Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen,

Scientific Data

2022

38

Page 1